By Ken Griffin, the billionaire founder and CEO of Citadel, has made his largest charitable contribution yet in his new home state of Florida.
A Generous Gift to Cancer Research
Griffin announced a $50 million donation to the Sylvester Comprehensive Cancer Center, affiliated with the University of Miami’s medical school, aimed at advancing cancer research. The contribution will facilitate the construction of a new 12-story research facility, which will bear Griffin’s name.
This substantial donation follows Griffin’s decision to cease donations to Harvard University due to concerns about how the institution addressed antisemitism on campus. Last year, he had donated over $300 million to Harvard’s Faculty of Arts and Sciences.
Impacting Florida’s Healthcare Landscape
Citadel’s relocation from Chicago to Miami in 2022 prompted Griffin’s increased involvement in Florida’s philanthropic and real estate spheres. Griffin has expressed optimism about Miami’s potential as a financial center, even suggesting it could surpass New York in the future.
As the founder of Citadel, a prominent hedge fund, and Citadel Securities, a leading trading firm, Griffin ranks as the 35th-richest person globally, with an estimated net worth of $38.6 billion according to Forbes.
The Kenneth C. Griffin Cancer Research Building
The newly funded research facility, named the Kenneth C. Griffin Cancer Research Building, is poised to become one of Florida’s largest standalone centers for cancer research. Expected to open its doors in 2025, the building will play a pivotal role in developing new therapies and expanding clinical trials in the fight against cancer.
Stuart A. Miller, board chair of the University of Miami Health System, hailed Griffin’s philanthropic leadership, emphasizing the positive impact of his generosity on local communities. Griffin’s significant contribution cements his status as a valuable asset to Miami and its healthcare landscape.